Overview
Single-Dose Escalation Study of IDX184 in Healthy Volunteers (MK-2355-002)
Status:
Completed
Completed
Trial end date:
2008-10-01
2008-10-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to obtain single dose safety and pharmacokinetic (PK) data of IDX184 in humans. No formal hypotheses are to be tested in this study.Phase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Merck Sharp & Dohme Corp.
Criteria
Inclusion Criteria:- Participants are in general good health.
- All participants of childbearing potential must have agreed to use a consistent form
of an acceptable double-barrier method of birth control
Exclusion Criteria:
- Participant is pregnant or breastfeeding.